RTI Surgical (RTIX) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of RTI Surgical (NASDAQ:RTIX) from a hold rating to a sell rating in a research note published on Tuesday morning.

According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “

How to Become a New Pot Stock Millionaire

Other equities research analysts also recently issued research reports about the company. Craig Hallum upgraded RTI Surgical from a hold rating to a buy rating in a report on Friday, March 2nd. BidaskClub upgraded RTI Surgical from a sell rating to a hold rating in a report on Wednesday, February 21st. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold.

Shares of RTI Surgical (NASDAQ RTIX) opened at $4.90 on Tuesday. RTI Surgical has a 1-year low of $3.58 and a 1-year high of $6.00. The stock has a market capitalization of $298.08, a price-to-earnings ratio of 245.00, a P/E/G ratio of 2.36 and a beta of 1.69. The company has a current ratio of 3.50, a quick ratio of 1.21 and a debt-to-equity ratio of 0.23.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, March 1st. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.04 by ($0.01). RTI Surgical had a return on equity of 2.88% and a net margin of 2.24%. The company had revenue of $70.82 million for the quarter, compared to the consensus estimate of $70.16 million. analysts forecast that RTI Surgical will post 0.14 EPS for the current fiscal year.

A number of institutional investors have recently made changes to their positions in RTIX. Paradigm Capital Management Inc. NY boosted its position in RTI Surgical by 2.3% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 5,930,217 shares of the medical equipment provider’s stock worth $24,314,000 after purchasing an additional 131,052 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in RTI Surgical by 1.6% in the third quarter. Dimensional Fund Advisors LP now owns 4,120,015 shares of the medical equipment provider’s stock worth $18,746,000 after purchasing an additional 63,083 shares during the last quarter. Vanguard Group Inc. boosted its position in RTI Surgical by 4.6% in the second quarter. Vanguard Group Inc. now owns 2,019,627 shares of the medical equipment provider’s stock worth $11,815,000 after purchasing an additional 88,758 shares during the last quarter. Renaissance Technologies LLC boosted its position in RTI Surgical by 7.2% in the fourth quarter. Renaissance Technologies LLC now owns 1,311,455 shares of the medical equipment provider’s stock worth $5,377,000 after purchasing an additional 87,900 shares during the last quarter. Finally, State Street Corp boosted its position in RTI Surgical by 10.4% in the second quarter. State Street Corp now owns 1,123,603 shares of the medical equipment provider’s stock worth $6,577,000 after purchasing an additional 106,204 shares during the last quarter. Institutional investors and hedge funds own 61.05% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “RTI Surgical (RTIX) Stock Rating Lowered by Zacks Investment Research” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://sportsperspectives.com/2018/03/10/rti-surgical-rtix-stock-rating-lowered-by-zacks-investment-research.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply